Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches

被引:126
作者
Wang, LQ
Wu, Q
Qiu, P
Mirza, A
McGuirk, M
Kirschmeier, P
Greene, JR
Wang, YL
Pickett, CB
Liu, SX [1 ]
机构
[1] Schering Plough Corp, Res Inst, Dept Tumor Biol, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, Res Inst, Human Genom Res Dept, Kenilworth, NJ 07033 USA
关键词
D O I
10.1074/jbc.M106570200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The completion of the human genome sequence (International Human Genome Sequence Consortium (2001) Nature 409, 860-921; Venter, J. C., et al (2001) Science 291, 1304-1351) allows for new ways to analyze global cellular regulatory mechanisms. Here we present a strategy to identify genes regulated by specific transcription factors in the human genome, and apply it to p53. We first collected promoters or introns of all genes available using two methods: GenBank (TM) annotation and a computationally derived transcript map. 4,852 genes analyzed in this way contained at least one p53 consensus binding sequence. Of 13 genes randomly selected for mRNA analysis, 11 were shown to respond to p53 expression. Five promoters were analyzed by chromatin immunoprecipitation, which revealed that all were bound by p53 in vivo. We then analyzed 33,615 unique human genes on cDNA microarrays, identifying 1,501 genes that respond to p53 expression. A parameter was derived that demonstrates that in silico prediction greatly enriches for genes that are activated and repressed by p53 and assists us to suggest other signaling pathways that may be connected to p53. The methods shown here illustrate a novel approach to analysis of global gene regulatory network through the integration of human genomic sequence information and genome-wide gene expression analysis.
引用
收藏
页码:43604 / 43610
页数:7
相关论文
共 36 条
[1]   Mechanisms of p53-mediated apoptosis [J].
Bates, S ;
Vousden, KH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :28-37
[2]   Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter [J].
Bian, JH ;
Sun, Y .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6330-6338
[3]   Further characterisation of the p53 responsive element - Identification of new candidate genes for trans-activation by p53 [J].
Bourdon, JC ;
DeguinChambon, V ;
Lelong, JC ;
Dessen, P ;
May, P ;
Debuire, B ;
May, E .
ONCOGENE, 1997, 14 (01) :85-94
[4]   INDUCTION OF THE GROWTH INHIBITOR IGF-BINDING PROTEIN-3 BY P53 [J].
BUCKBINDER, L ;
TALBOTT, R ;
VELASCOMIGUEL, S ;
TAKENAKA, I ;
FAHA, B ;
SEIZINGER, BR ;
KLEY, N .
NATURE, 1995, 377 (6550) :646-649
[5]   p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor [J].
Budhram-Mahadeo, V ;
Morris, PJ ;
Smith, MD ;
Midgley, CA ;
Boxer, LM ;
Latchman, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :15237-15244
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]   Human smooth muscle α-actin gene is a transcriptional target of the p53 tumor suppressor protein [J].
Comer, KA ;
Dennis, PA ;
Armstrong, L ;
Catino, JJ ;
Kastan, MB ;
Kumar, CC .
ONCOGENE, 1998, 16 (10) :1299-1308
[8]   Functional protection by acute phase proteins α1-acid glycoprotein and α1-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation [J].
Daemen, MARC ;
Heemskerk, VH ;
van 't Veer, C ;
Denecker, G ;
Wolfs, TGAM ;
Vandenabeele, P ;
Buurman, WA .
CIRCULATION, 2000, 102 (12) :1420-1426
[9]   DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49
[10]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825